Instruments and reagents for blood analysis

Boule Diagnostics

Boule Diagnostics is a Swedish diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics, specializing in blood cell counting (CBC) systems, in both human and veterinary hematology. Boule Diagnostics is a global company with approximately 170 employees located in Sweden, USA and Mexico and with a market presence via distributors in addition to its own sales and marketing organisation in more than 100 countries.

Financials

BOULE DIAGNOSTICS

SEKm 2017 2018 2019
Sales 428 434 480
Sales growth (%) 7,8 1,5 10,7
EBITDA 65 76 89
EBITDA margin (%) 15,3 17,5 18,6
EBIT adj 54 67 79
EBIT adj margin (%) 12,7 15,4 16,4
Pretax profit 53 67 78
EPS rep 1,94 2,59 3
EPS growth (%) 1,5 33,1 16,1
EPS adj 1,94 2,59 3
DPS 0,5 1 1
EV/EBITDA (x) 17,7 14,5 12,1
EV/EBIT adj (x) 21,3 16,4 13,7
P/E (x) 33,7 23,4 20,2
P/E adj (x) 33,7 23,4 20,2
EV/sales (x) 2,7 2,5 2,3
FCF yield (%) 3,5 -1,6 2,9
Dividend yield (%) 0,8 1,7 1,7
Net IB debt/EBITDA -1,7 -1,5 -1,4

Main shareholders

Boule Diagnostics

Main shareholders Share capital % Voting shares %
Martin Gren (Grenspecialisten) 10.7 % 10.7 %
Svolder 10.0 % 10.0 %
SEB Fonder 7.7 % 9.7 %
Thomas Eklund 9.3 % 9.3 %
Swedbank Robur Fonder 9.2 % 9.2 %
Tredje AP-fonden 6.3 % 6.3 %
Handelsbanken Fonder 6.0 % 6.0 %
Länsförsäkringar Fonder 4.4 % 4.4 %
Norges Bank 2.4 % 2.4 %
Lannebo Fonder 2.1 % 2.1 %